View Older Stories View More Recent Stories
-
ATTENTION ORGANON & CO. (OGN) SHAREHOLDERS: Securities Fraud Lawsuit Filed Against Organon & Co.
-
OGN LEGAL ALERT: BFA Law Notifies Organon & Co. Investors of the Imminent July 22 Securities Fraud Class Action Deadline
-
Faruqi & Faruqi Reminds Organon Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2025 - OGN
-
ORGANON & CO. (OGN) INVESTOR ALERT: Berger Montague Advises Investors to Inquire About a Securities Fraud Class Action
-
ROSEN, A LONGSTANDING FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
-
OGN LEGAL NEWS: Organon & Co. Investors with Losses are Notified to Contact BFA Law about the Pending Class Action Lawsuit
-
OGN INVESTOR DEADLINE: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
-
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
-
OGN INVESTOR REMINDER: BFA Law Reminds Organon & Co. Investors to Contact the Firm by the July 22 Class Action Deadline
-
INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
-
ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
-
Faruqi & Faruqi Reminds Organon Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of July 22, 2025 - OGN
-
OGN INVESTOR ALERT: Organon & Co. Shareholders are Notified to Contact BFA Law by the July 22 Securities Fraud Class Action Deadline
-
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
-
SHAREHOLDER ACTION REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
-
OGN LAWSUIT DEADLINE: BFA Law Notifies Organon & Co. Investors to Contact the Firm before the July 22 Securities Class Action Deadline
-
OGN INVESTOR ALERT: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Investor Class Action Lawsuit
-
OGN Investors Have the Opportunity to Lead the Organon Securities Fraud Lawsuit with Faruqi & Faruqi, LLP
-
OGN STOCK NEWS: Organon & Co. Shareholders are Reminded of the Upcoming July 22 Securities Class Action Deadline
-
STOCKHOLDER ALERT: Pending Securities Fraud Lawsuit Against Organon & Co. (OGN)
-
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
-
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
ONGOING DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
-
OGN CLASS ALERT: Organon & Co. Investors with Losses are Notified to Contact BFA Law about the Securities Fraud Class Action
-
ROSEN, A LEADING LAW FIRM, Encourages Organon & Co. Investors to Secure Counsel Before Important Deadline in Securities Class Action - OGN
-
OGN DEADLINE: BFA Law Alerts Organon & Co. Investors of the Pending July 22 Class Action Deadline
-
OGN INVESTOR NOTICE: Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
OGN SECURITES: Organon & Co. Investors with Losses are Alerted to Contact BFA Law before the Upcoming July 22 Securities Fraud Class Action Deadline
-
DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Organon
-
Organon (OGN) and Samsung Bioepis Granted FDA Interchangeability Designation
-
OGN INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Organon & Co. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
-
Organon & Co. (OGN) PT Lowered to $16 at BNP Paribas Exane
-
OGN INVESTIGATION: Investigation Launched into Organon & Co. and Attorneys Encourage Investors with Substantial Losses or Witnesses with Relevant Information to Contact Law Firm
-
These 2 sectors are under-owned, Barclays says and advises where to invest
-
Increasing unusual put option volume: PACB SN SRPT OGN UWMC WEN AGL UAA WMB JCI OSCR EVGO
-
Organon (OGN) Tops Q1 EPS by 11c; offers guidance
-
Increasing unusual put option volume: EDU OGN FIVN AZUL STX VSCO INVZ DFS ZI ASO XLI BDX FXE
-
Organon (OGN) Appoints Ramona A. Sequeira to its Board
-
Organon (OGN) Acquires TOFIDENCE
-
Organon (OGN) call put ratio 47 calls to 1 put with focus on March 17.50 calls
-
Organon (OGN) March 17.50 calls active as share price down 5.6%
-
Organon & Co. (OGN) PT Lowered to $19 at Goldman Sachs
-
Organon (OGN) Misses Q4 EPS by 1c ; Offers Guidance
-
TD Cowen Assumes Organon & Co. (OGN) at Hold
-
TD Cowen on Pharma: '10 Events in 2025 That Could Change Practice, Alter Companies, Move Stocks'
-
TD Cowen on Trump Tariffs and Other Risks: 'Where Does Pharma Stand?'
-
Organon (OGN) Announces FDA Approval of VTAMA cream
-
Organon (OGN) Issues Update on FDA Review of VTAMA Cream
-
Organon (OGN) Misses Q3 EPS by 3c, provides guidance
